These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy. Maspero JF; Dueñas-Meza E; Volovitz B; Pinacho Daza C; Kosa L; Vrijens F; Leff JA Curr Med Res Opin; 2001; 17(2):96-104. PubMed ID: 11759189 [TBL] [Abstract][Full Text] [Related]
5. Comparison of inhaled corticosteroid combined with theophylline and double-dose inhaled corticosteroid in moderate to severe asthma. Wang Y; Wang CZ; Lin KX; Qian GS; Zhuo WL; Li SP; Zhao ZQ; Liao XQ; Song YX Respirology; 2005 Mar; 10(2):189-95. PubMed ID: 15823184 [TBL] [Abstract][Full Text] [Related]
6. Randomized trial of inhaled beclomethasone dipropionate versus theophylline for moderate asthma during pregnancy. Dombrowski MP; Schatz M; Wise R; Thom EA; Landon M; Mabie W; Newman RB; McNellis D; Hauth JC; Lindheimer M; Caritis SN; Leveno KJ; Meis P; Miodovnik M; Wapner RJ; Varner MW; O'Sullivan MJ; Conway DL; ; Am J Obstet Gynecol; 2004 Mar; 190(3):737-44. PubMed ID: 15042007 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study. Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991 [TBL] [Abstract][Full Text] [Related]
8. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023). Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M; Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834 [TBL] [Abstract][Full Text] [Related]
9. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study. Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690 [TBL] [Abstract][Full Text] [Related]
10. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial). Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768 [TBL] [Abstract][Full Text] [Related]
11. [The quality of life of the asthmatic child caregiver]. Sienra-Monge JJ; del Río-Navarro BE; Alvarez-Amador M; Blandon-Vijil V; Chico-Velasco RG Gac Med Mex; 2004; 140(2):139-45. PubMed ID: 15162946 [TBL] [Abstract][Full Text] [Related]
12. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma? Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683 [TBL] [Abstract][Full Text] [Related]
13. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC; Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493 [TBL] [Abstract][Full Text] [Related]
14. [Contribution of salmeterol in ambulatory practice to the improvement of asthma and quality of life in childhood]. Robert J; Desfougères JL Allerg Immunol (Paris); 2002 Oct; 34(8):287-92. PubMed ID: 12449667 [TBL] [Abstract][Full Text] [Related]
15. Fluticasone for the treatment of symptomatic bronchial asthma in children treated with sodium cromogylate--a prospective, randomised trial. von Berg A; Gappa M; Steinkamp G; Eur J Med Res; 2002 Jun; 7(6):257-64. PubMed ID: 12117660 [TBL] [Abstract][Full Text] [Related]
16. Double-blind, randomised, controlled trial assessing controller medications in asthma. Shah AR; Sharples LD; Solanki RN; Shah KV Respiration; 2006; 73(4):449-56. PubMed ID: 16407639 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma. Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of combined therapy efficacy with disodium cromoglycate and salmeterol in children with atopic bronchial asthma]. Hofman J; Swiebocka E Pol Merkur Lekarski; 1997 Oct; 3(16):168-70. PubMed ID: 9461722 [TBL] [Abstract][Full Text] [Related]
20. Use of allergen bronchoprovocation to screen drugs for anti-asthma activity. Hendeles L; Harman E Pharmacotherapy; 1997; 17(1 Pt 2):39S-49S. PubMed ID: 9017787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]